Results 21 to 30 of about 187,113 (345)
Farmacja Polska, 2021 Non-alcoholic fatty liver disease (NAFLD) is categorised into simple steatosis, termed nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH).
Katarzyna Juszczyńska
doaj +1 more source
To identify and examine the different causes of liver disease in Sri Lanka [PDF]
, 2017 © 2017 The Authors. Published by International Journal of Science and Research. This is an open access article available under a Creative Commons licence.
Aslam, Fahim, Kulasena, Hashan
core +1 more source
Non‐alcoholic fatty liver disease
Journal of Diabetes, 2012 AbstractNon‐alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world. It is closely associated with metabolic syndrome. The alarming epidemics of diabetes and obesity have fueled an increasing prevalence of NAFLD, particularly among these high‐risk groups.
Ana C, Tuyama, Charissa Y, Chang
openaire +2 more sources
Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome [PDF]
, 2016 There is evidence from animal and in-vitro studies that activation of the endocannabinoid system (EC) through cannabinoid receptor 1 (CB-1) is associated with liver injury, inflammation and hepatocellular carcinoma.1 Data suggests endogenous cannabinoids
Ahmed, Lina +6 more
core +1 more source
Oxidative stress: new insights on the association of nonalcoholic fatty liver disease and atherosclerosis [PDF]
, 2015 Non-alcoholic fatty liver disease (NAFLD) represents the most common and emerging chronic liver disease worldwide. It includes a wide spectrum of liver diseases ranging from simple fatty liver to non-alcoholic steatohepatitis (NASH), which may progress ...
Albanese, Fabiana +7 more
core +1 more source
Immunoglobulin A and liver diseases. [PDF]
, 2017 Immunoglobulin A (IgA) is a major immunoglobulin isotype in the gut and plays a role in maintenance of gut homeostasis. Secretory IgA (SIgA) has multiple functions in the gut, such as to regulate microbiota composition, to protect intestinal epithelium ...
Inamine, Tatsuo, Schnabl, Bernd
core +2 more sources
Pediatric Non-Alcoholic Fatty Liver Disease [PDF]
Children, 2017 Abstract: With the increase in the prevalence of obesity, non-alcoholic fatty liver disease (NAFLD) has become among the leading causes of chronic liver disease in the pediatric age group. Once believed to be a “two-hit process”, it is now clear that the actual pathophysiology of NAFLD is complex and involves multiple pathways.
Haley Bush +2 more
openaire +3 more sources
Non‐alcoholic fatty liver disease proteomics [PDF]
PROTEOMICS – Clinical Applications, 2010 AbstractPurpose: Non‐alcoholic fatty liver disease (NAFLD) is an important cause of chronic liver injury that has gained concern in clinical hepatology. The principal aim of this study was to find differences in protein expression between patients with NAFLD and healthy controls.Experimental design: Changes in protein expression of liver samples from ...
Eva, Rodríguez-Suárez +11 more
openaire +2 more sources
An Exploration of the Treatment of Non-Alcoholic Fatty Liver Disease Based on Dietary Factors [PDF]
BIO Web of ConferencesNon-alcoholic fatty liver disease is a clinical pathological syndrome characterized by diffuse hepatocellular macrovesicular steatosis caused by other liver-damaging factors except for alcohol.
Yang Wanzhou
doaj +1 more source
Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway. [PDF]
PLoS ONE, 2016 Non-alcoholic fatty liver disease is one of the most important causes of liver-related morbidity in children. In non-alcoholic fatty liver disease, the activation of liver resident macrophage pool is a central event in the progression of liver injury ...
Guido Carpino +10 more
doaj +1 more source